Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name REC-2282
Trade Name
Synonyms AR-42|HDAC42|AR42|AR 42||REC2282|REC 2282
Drug Descriptions

REC-2282 (AR-42) is a histone deacetylase (HDAC) inhibitor, which may lead to increased apoptosis of tumor cells and decreased tumor growth (PMID: 23178755, PMID: 21778190).

DrugClasses HDAC Inhibitor 44
CAS Registry Number 935881-37-1
NCIT ID C116850


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cisplatin + REC-2282 Cisplatin REC-2282 0 0
Decitabine + REC-2282 Decitabine REC-2282 0 1
Dexamethasone + Pomalidomide + REC-2282 Dexamethasone Pomalidomide REC-2282 0 1
Pazopanib + REC-2282 Pazopanib REC-2282 0 1
REC-2282 REC-2282 2 2

Additional content available in CKB BOOST